Aberdeen Group’s Cerence CRNC Stock Holding History

Aberdeen Group’s Portfolio CRNC Stock Details CRNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-509,387	Closed	-$39M	–	992
2021 Q4	$39M	Buy	509,387 +12,983	+3%	+$1.14M	0.09%	234
2021 Q3	$47.7M	Buy	496,404 +147,817	+42%	+$16.1M	0.11%	193
2021 Q2	$37.2M	Buy	+348,587	New	+$34.3M	0.08%	234

Other funds holding CRNC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VVP

Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Aberdeen Group's CRNC Position: Q1 2022 in Review

Aberdeen Group sold out of Cerence (CRNC) in Q1 2022, closing a stake of 509,387 shares — an estimated $39M sold.

Aberdeen Group first reported a position in CRNC in Q2 2021 and held it in 3 quarters. The position peaked at $47.7M in Q3 2021. 286 funds tracked by Wall St. Rank hold CRNC as of Q1 2022.

Aberdeen Group reported no remaining Cerence position as of Q1 2022 after selling out during the quarter.
Aberdeen Group sold 509,387 Cerence shares in Q1 2022, an estimated $39M.
Aberdeen Group first reported a position in Cerence in Q2 2021 and held it in 3 quarters.
Aberdeen Group's Cerence position peaked at $47.7M in Q3 2021.
286 funds tracked by Wall St. Rank held Cerence as of Q1 2022.

Based on Aberdeen Group's 13F filing for Q1 2022, filed 4 May 2022.